enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Alnylam Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Alnylam_Pharmaceuticals

   Alnylam still does not earn money, but writes losses. The losses ("GAAP Operating Loss") from Alnylam were around $650 million in the late 2020. Alnylam expects to achieve net profits financially in 2022 or 2023. [40] In July 2023, Roche partnered with Alnylam Pharmaceuticals in a deal worth $2.8 billion for the development of a hypertension ...

3. Alnylam's Biggest Opportunities - AOL

   www.aol.com/news/2013-10-01-alnylams-biggest...

   Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY), a biotech company developing a new class of medications based on RNAi technology, have soared 250% since the start of 2013. Why are investors so ...

4. Yvonne Greenstreet - Wikipedia

   en.wikipedia.org/wiki/Yvonne_Greenstreet

   Yvonne Greenstreet is the daughter of a Ghanaian mother, Miranda Greenstreet, and a white Englishman. The pair met in the 1950s as students at the London School of Economics.

5. Robert J. Desnick - Wikipedia

   en.wikipedia.org/wiki/Robert_J._Desnick

   Robert J. Desnick is an American human geneticist whose basic and translational research accomplishments include significant discoveries in genomics, pharmacogenetics, gene therapy, personalized medicine, and the treatment of genetic diseases.

6. Regulus Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Regulus_Therapeutics

   Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. [1] microRNA explained

7. Alnylam Provides Key 2013 - 2014 Goals for RNAi ... - AOL

   www.aol.com/news/2013-01-06-alnylam-provides-key...

   Alnylam Provides Key 2013 - 2014 Goals for RNAi Therapeutics Pipeline - Aims to Advance ALN-TTR02 into Phase III Pivotal Trial in Transthyretin (TTR)-Mediated Amyloidosis (ATTR) Patients with ...

8. Alnylam to appeal ruling on patents related to Moderna's ...

   www.aol.com/news/alnylam-appeal-ruling-patents...

   (Reuters) -Alnylam Pharmaceuticals said on Friday it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents asserted against Moderna for the latter's COVID ...

9. Why Is Alnylam (ALNY) Up 3.1% Since Last Earnings Report? - AOL

   www.aol.com/news/why-alnylam-alny-3-1-143102800.html

   For premium support please call: 800-290-4726 more ways to reach us